Novo Nordisk A/S buy skatcup
Start price
02.04.22
/
50%
€101.00
Target price
02.04.23
€150.00
Performance (%)
45.52%
End price
03.04.23
€146.98
Summary
This prediction ended on 03.04.23 with a price of €146.98. With a performance of 45.52% the BUY prediction by skatcup was a big success. A total of €1.18 was paid as dividends for this prediction. skatcup has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S | - | - | - |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
Comments by skatcup for this prediction
In the thread Novo Nordisk A/S diskutieren
Buy mit Kursziel 120,0
Kursziel geändert auf 150,0
In the thread Trading Novo Nordisk A/S
Die von skatcup gewählte maximale Laufzeit wurde überschritten